Temeka Dawn Lewis-Wolfson
2PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Dec 28, 2022
Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner
|Oct 31, 2022
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.Nancy Kierstin Reid, Kayla Rena Joyner, Temeka Dawn Lewis-Wolfson
Pageof 1
